REPRODUCTIVE HORMONE MARKET ANALYSIS
Reproductive Hormone Market - Drivers
The reproductive hormone market size is expected to increase over the forecast period, owing to rising drug approvals of reproductive hormones. For instance, in 2018, TherapeuticsMD Inc. received the U.S. FDA approval for its BIJUVA (Estradiol and Progesterone) Capsules for treatment of vasomotor symptoms associated with menopause.
Furthermore, increasing number of infertility in women is expected to drive growth of this market. For instance, in 2010, according to WHO, there were 48.5 million infertile couples, globally. Additionally, according to a survey conducted by Centers for Disease Control and Prevention, in between 2006-2010, 1 in 8 couples had faced problems of sustaining pregnancy in the U.S. Therefore, such increasing burden of infertility across the globe, is expected to drive growth of the reproductive hormone market.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
